Ren Sheng Jiang
Presidente en CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. .
Fortuna: 5 621 M $ al 30/04/2024
Relaciones activas
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Lin Yuan | M | 60 | 10 años | |
| Chun Sheng Li | M | - |
Chongqing Genrix Biopharmaceutical Co., Ltd.
 Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 2 años |
| Fei Qin | M | 38 | 14 años | |
| Zhen Jing Li | M | 42 | 10 años | |
| Ling Feng Jiang | M | 44 | 12 años | |
| Jie Xun | F | 35 | 7 años | |
| Hai Ping Xu | F | 43 | 10 años | |
| Li Chen | M | 47 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 2 años |
| Dong Zhi Wei | M | 61 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 2 años |
| Li Wen Liu | M | 33 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 3 años |
| Zhi Gang Liu | M | 51 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 4 años |
| Zhi Yuan Chang | M | 44 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 9 años |
| Yun Tong Hu | M | 42 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 2 años |
| Jing Zhang | F | 55 | 17 años | |
| Ji Kuan Shan | M | 52 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 9 años |
| Yu Zhang | F | 37 | 19 años | |
| Xu Jiang Chen | M | 51 | 3 años | |
| Zhi Jun Wang | M | 58 | 5 años | |
| Shi Long Yang | M | 61 | 6 años | |
| Tao Gong | M | 55 | 3 años | |
| Jia Qian Yang | F | 42 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 3 años |
| Min Kou | F | 39 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 7 años |
| Hong Fan | F | 36 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 7 años |
| Jun Hua Qian | M | 57 |
Chongqing Genrix Biopharmaceutical Co., Ltd.
Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. | 3 años |
| Lin Du | M | 59 | 7 años | |
| Yue Ming He | F | 29 | 2 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Yan Chun Xu | F | 52 | - | |
| Nong Yu | M | 59 | - | |
| Xin Rong Zhang | F | 65 | - | |
| Hui Ming Chen | M | - | 5 años | |
| Guan Jiang Wu | M | 56 | - | |
| Yu Feng Chen | M | 60 | - | |
| Cai Shen Yue | M | 59 | - | |
| Jing Fu Qiu | M | 57 | 6 años | |
| Bao Kui Liu | M | 70 | 6 años | |
| Gang Deng | M | 55 | 1 años | |
| Xi Sheng Jiang | M | 64 | - | |
| Yu Qin Wu | F | 55 | 5 años | |
| Jing Li | F | 41 | - |
Estadísticas
| País | Relaciones | % del total |
|---|---|---|
| China | 39 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Ren Sheng Jiang
- Red Personal
